Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve)

Clinical trial NCT00095238 · COMPLETED

Trial details

NCT number: NCT00095238
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Congestive Heart Failure

Start date: 2002-06-01
Primary completion: 2008-07-01
Enrollment: 4128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.